blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1251871

EP1251871 - PHARMACEUTICAL COMPOSITION FOR IMMUNOMODULATION AND PREPARATION OF VACCINES COMPRISING AN ANTIGEN AND AS ADJUVANTS AN IMMUNOGENIC OLIGODEOXYNUCLEOTIDE AND A POLYCATIONIC POLYPEPTIDE [Right-click to bookmark this link]
Former [2002/44]PHARMACEUTICAL COMPOSITION FOR IMMUNOMODULATION AND PREPARATION OF VACCINES COMPRISING AN ANTIGEN AND AN IMMUNOGENIC OLIGODEOXYNUCLEOTIDE AND A POLYCATIONIC POLYMER AS ADJUVANTS
[2007/25]
StatusNo opposition filed within time limit
Status updated on  27.02.2009
Database last updated on 14.09.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Intercell AG
Campus Vienna Biocenter 6
1030 Wien / AT
[2008/13]
Former [2002/44]For all designated states
Cistem Biotechnologies GmbH
Rennweg 95 B
1030 Vienna / AT
Inventor(s)01 / LINGNAU, Karen
Gallgasse 8/10
A-1130 Vienna / AT
02 / MATTNER, Frank
Krottenbachstrasse 267/D12
A-1190 Vienna / AT
03 / SCHMIDT, Walter
Steingasse 18/1/10
A-1030 Vienna / AT
04 / BIRNSTIEL, Max
Nucleo
CH-6953 Lugaggia / CH
05 / BUSCHLE, Michael
Goethestrasse 2/2/9
A-2380 Perchtoldsdorf / AT
 [2002/44]
Representative(s)Alge, Daniel, et al
Sonn Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2002/44]Alge, Daniel, Mag. Dr. rer.nat., et al
Patentanwälte Sonn, Pawloy, Weinzinger & Köhler-Pavlik Riemergasse 14
1010 Wien / AT
Application number, filing date01903625.005.01.2001
[2002/44]
WO2001EP00087
Priority number, dateAT2000000012928.01.2000         Original published format: AT 1292000
[2002/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0154720
Date:02.08.2001
Language:EN
[2001/31]
Type: A1 Application with search report 
No.:EP1251871
Date:30.10.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 02.08.2001 takes the place of the publication of the European patent application.
[2002/44]
Type: B1 Patent specification 
No.:EP1251871
Date:23.04.2008
Language:EN
[2008/17]
Search report(s)International search report - published on:EP02.08.2001
ClassificationIPC:A61K39/39, A61K39/002, A61K39/02, A61K39/12, A61P35/00, A61P37/00, A61K31/722, A61K31/7125, C07K14/34
[2007/41]
CPC:
A61K39/39 (EP,US); A61P31/04 (EP); A61P31/12 (EP);
A61P33/00 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/04 (EP); A61P37/06 (EP); A61K2039/555 (EP,US);
A61K2039/55561 (EP,US) (-)
C-Set:
A61K39/39, A61K2300/00 (US,EP);
A61K39/39, A61K39/00, A61K38/02 (EP,US)
Former IPC [2002/44]A61K39/39, A61K39/002, A61K39/02, A61K39/12, A61P35/00, A61P37/00, A61K31/722, A61K31/7125, C07K14/34, // C07K14:155
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/44]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR IMMUNSTIMULATION UND ZUR ZUBEREITUNG VON IMPFSTOFFEN ENTHALTEND EIN ANTIGEN, UND ALS ADJUVANTIEN EIN IMMUNOGENES OLIGODESOXYNUKLEOTID UND EIN POLYKATIONISCHES POLYPEPTID[2007/37]
English:PHARMACEUTICAL COMPOSITION FOR IMMUNOMODULATION AND PREPARATION OF VACCINES COMPRISING AN ANTIGEN AND AS ADJUVANTS AN IMMUNOGENIC OLIGODEOXYNUCLEOTIDE AND A POLYCATIONIC POLYPEPTIDE[2007/25]
French:COMPOSITION PHARMACEUTIQUE POUR IMMUNOMODULATION ET PREPARATION DE VACCINS COMPRENANT UN ANTIGENE, ET COMME ADJUVANTS UN OLIGODESOXYRIBONUCLEOTIDE IMMUNOGENE ET UN POLYPEPTIDE POLYCATIONIQUE[2007/25]
Former [2002/44]PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR IMMUNSTIMULATION UND ZUR ZUBEREITUNG VON IMPFSTOFFEN ENTHALTEND EIN ANTIGEN, EIN IMMUNOGENES OLIGOOXYNUKLEOTID UND EIN POLYKATIONISCHES POLYMER ALS ADJUVANTIEN
Former [2002/44]PHARMACEUTICAL COMPOSITION FOR IMMUNOMODULATION AND PREPARATION OF VACCINES COMPRISING AN ANTIGEN AND AN IMMUNOGENIC OLIGODEOXYNUCLEOTIDE AND A POLYCATIONIC POLYMER AS ADJUVANTS
Former [2002/44]COMPOSITION PHARMACEUTIQUE POUR IMMUNOMODULATION ET PREPARATION DE VACCINS COMPRENANT UN ANTIGENE, UN OLIGODESOXYRIBONUCLEOTIDE IMMUNOGENE ET POLYMERE POLYCATIONIQUE SOUS FORME D'ADJUVANTS
Entry into regional phase18.07.2002National basic fee paid 
18.07.2002Designation fee(s) paid 
18.07.2002Examination fee paid 
Examination procedure23.08.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.07.2002Examination requested  [2002/44]
13.03.2006Despatch of a communication from the examining division (Time limit: M02)
10.05.2006Reply to a communication from the examining division
15.06.2007Despatch of a communication from the examining division (Time limit: M02)
27.07.2007Reply to a communication from the examining division
21.09.2007Communication of intention to grant the patent
24.12.2007Fee for grant paid
24.12.2007Fee for publishing/printing paid
Opposition(s)26.01.2009No opposition filed within time limit [2009/14]
Fees paidRenewal fee
21.01.2003Renewal fee patent year 03
19.01.2004Renewal fee patent year 04
15.01.2005Renewal fee patent year 05
14.01.2006Renewal fee patent year 06
13.01.2007Renewal fee patent year 07
16.01.2008Renewal fee patent year 08
11.03.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.04.2008
BE23.04.2008
CY23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
TR23.04.2008
SE23.07.2008
GR24.07.2008
PT23.09.2008
IE05.01.2009
LU05.01.2009
[2011/43]
Former [2011/21]AT23.04.2008
BE23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
GR24.07.2008
PT23.09.2008
IE05.01.2009
LU05.01.2009
Former [2010/47]AT23.04.2008
BE23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
GR24.07.2008
PT23.09.2008
IE05.01.2009
Former [2010/07]AT23.04.2008
BE23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
PT23.09.2008
IE05.01.2009
Former [2009/14]AT23.04.2008
BE23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
PT23.09.2008
Former [2009/08]AT23.04.2008
DK23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
PT23.09.2008
Former [2009/07]AT23.04.2008
FI23.04.2008
NL23.04.2008
SE23.07.2008
PT23.09.2008
Former [2008/49]AT23.04.2008
FI23.04.2008
NL23.04.2008
PT23.09.2008
Cited inInternational search[A]US5109026  (HOSKINSON RONALD M [AU], et al) [A] 1-10 * abstract *;
 [A]WO9730721  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-11 * abstract *;
 [A]WO9938528  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-11 * page 8; claim 1 *;
 [A]  - BUSCHLE M ET AL, "Transloading of tumor antigen-derived peptides into antigen-presenting cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, (19970401), vol. 94, ISSN 0027-8424, pages 3256 - 3261, XP002086009 [A] 1-11 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.94.7.3256
 [A]  - BUSCHLE M ET AL, "DEVELOPMENT OF DEFINED, SYNTHETIC VACCINES BY IN VIVO CHARGING OF ANTIGEN PRESENTING CELLS WITH ANTIGEN", JOURNAL OF INVESTIGATIVE DERMATOLOGY,NEW YORK, NY,US, (200001), vol. 114, no. 1, ISSN 0022-202X, page 235, XP000996450 [A] 1-11 * the whole document *
 [A]  - GALL D ET AL, "ADJUVANT ACTIVITY OF POLYELECTROLYTES", IMMUNOLOGY,OXFORD,GB, (1972), vol. 23, no. 4, ISSN 0019-2805, pages 569 - 575, XP000995977 [A] 1-11 * page 570 *
 [A]  - SCHMIDT ET AL., "Cell-free tumor antigen peptide-based cancer vaccines", PNAS, (199704), vol. 94, pages 3262 - 3267, XP002168512 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.94.7.3262
 [A]  - MCCLUSKIE M J ET AL, "NOVEL STRATEGIES USING DNA FOR THE INDUCTION OF MUCOSAL IMMUNITY", CRITICAL REVIEWS IN IMMUNOLOGY,CRC PRESS, INC,XX, (1999), vol. 19, no. 4, ISSN 1040-8401, pages 303 - 329, XP000995880 [A] 1-11 * the whole document *
Examination   - TOSSI ET AL, "Amphipathic, alpha-helical antimicrobial peptides.", BIOPOLYMERS, (2000), vol. 55, no. 30, pages 4 - 30
    - MCCLUSKIE; DAVIES, "CpG DNA as mucosal adjuvant", VACCINE, (2000), vol. 18, pages 231 - 237
    - DALLAS; FALKOW, "Amino acid sequence homology between cholera toxin and Escherichia Coli heat-labile toxin", NATURE, (198012), vol. 288, no. 4, pages 499 - 501
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.